Menu

Read It - Latest News Update

Connect with us

Merck says its antiviral pill is less effective in a final analysis.

Source: NYTimes.com

The drug, molnupiravir, reduced the risk of hospitalization and death in high-risk Covid patients by 30 percent. An earlier analysis had found a 50 percent reduction.... Read More

Source: NYTimes.com
Published: 2021-11-26T14:02:27-05:00
Author: By Rebecca Robbins